It also further affirmed the potential prognostic significance of IDH1 mutation in glioblastoma (Nobusawa et al., 2009; Yan et al., 2009; Molenaar et al., 2014), which was also consistent with our focus on IDH1 in clinical works (Table 2; Figure 6). This evidence concerns the gene IDH1 and glioblastoma.